VIVEbiotech obtains the CIR Certification from the Ministry of Higher Education, Research and Innovation of the Government of France

VIVEbiotech S.L. has obtained the CIR certification (Crédit d'Impôt Recherche) which reinforces its position as an R & D provider for the French market.

Granted by the "Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation", the awarding of the certificate demonstrates the important R&D activity that takes place in VIVEbiotech, and will allow French clients to obtain important tax deductions on R&D services hired to the company.

In addition to manufacturing clinical quality lentiviral vectors, VIVEbiotech has a research laboratory in which important research activities are carried out to overcome the main barriers that exist today in the gene therapy field: 1) the achievement of more cost-effective processes and 2) the enchancement of the safety profile of lentiviral vectors. VIVEbiotech is working on the improvement of producer cell lines, on new pseudo-typing strategies, and on the development of its own worldwide licensed technology: a non-integrative episomal stable lentiviral vector called LENTISOMA.

For more information about the certification and its processing, go to the Ministry's website:

Contact us

Mikeletegi Pasealekua 81, San Sebastián 20009, Gipuzkoa (SPAIN)